Aviation Medication Transparency Act of 2024
Bill Number: H.R. 9243
Introduced: August 2, 2024 by Rep. Sean Casten and Rep. Rudy Yakym
Committee: House Committee on Transportation and Infrastructure
Summary
This bipartisan bill requires the FAA Administrator to publish a comprehensive, annually updated list of medications relevant to airman medical certification. The list must identify allowable medications, disqualifying ones ("Do Not Issue"), and stabilization timelines, and it must be developed in consultation with pilots, ATCs, and relevant stakeholders. It must be published in a clear and accessible format for all pilots, especially those entering the certification process.
Relevance to P4HR
- ✔ Brings transparency to an otherwise opaque and inconsistent medication policy landscape.
- ✔ Reduces AME and FAA discretion by mandating standardization and clarity.
- ✔ Enables pilots to make informed medical and treatment decisions without fear of unknowingly jeopardizing certification.
- ✔ Aligns with P4HR's mission to ensure fairness, due process, and pilot-led reform in the FAA medical process.
Call to Action
P4HR supports this bill as a foundational step toward medical certification reform. We encourage all supporters to contact their representatives in support of H.R. 9243. Let Congress know that pilots demand clarity, fairness, and transparency.